Orgenesis (NASDAQ: ORGS)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Orgenesis (NASDAQ: ORGS) through any online brokerage.
The latest price target for Orgenesis (NASDAQ: ORGS) was reported by Benchmark on Thursday, September 26, 2019. The analyst firm set a price target for 9.00 expecting ORGS to rise to within 12 months (a possible 291.30% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Orgenesis (NASDAQ: ORGS) is $2.3 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Orgenesis.
Orgenesis’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Orgenesis.
Orgenesis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.